EUVIMEDEUVIMED entdecken
Open Access

Chemoradiotherapy With Generic Cisplatin Formulations for Head and Neck Cancers

Rie Shimada, Kiyoaki Tsukahara, Soichiro Takase, Isaku Okamoto, Hiroki Sato, Yasuaki Katsube, Ryo Maruyama, Akira Shimizu

Japanese Clinical Medicine · 2018

DOI: 10.1177/1179670717749231 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Japanese Clinical Medicine, 2018. Verfasst von Rie Shimada und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology, Head and Neck Surgery, Tokyo Medical University, Tokyo, Japan. Die Arbeit nennt 14 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The use of generic drugs has been increasing. However, studies of the safety of generic cisplatin (CDDP) for the treatment of head and neck cancer (HNC) have not been reported. This study investigated the treatment completion rates and incidence of CDDP-related adverse events in patients with advanced HNC treated with concurrent chemoradiotherapy (CRT) using generic CDDP. This study included 72 patients who received concurrent CRT using generic CDDP. The number of courses of CDDP was 3 in 45 patients, 2 in 19 patients, and 1 in 8 patients. During 154 courses of 80 mg/m 2 generic CDDP, grade 3/4 leukopenia in 21 (14%), neutropenia in 18 (12%), and hypochromia in 8 (5%) cases were reported. Grade 2 elevated serum creatinine occurred in 4 cases (3%), but no grade 3/4 elevated serum creatinine was reported. These results suggest that CRT using generic CDDP is well tolerated in patients with HNC.

Schlagwörter

Stichwörter der Autor:innen

Generic cisplatin formulationschemoradiotherapychemotherapyhead and neck cancer

Autor:innen und Institutionen

  • Department of Otorhinolaryngology, Head and Neck Surgery, Tokyo Medical University, Tokyo, Japan.

Zitieren

APA

Shimada, R., Tsukahara, K., Takase, S., Okamoto, I., Sato, H., Katsube, Y., Maruyama, R., & Shimizu, A. (2018). Chemoradiotherapy With Generic Cisplatin Formulations for Head and Neck Cancers. Japanese Clinical Medicine. https://doi.org/10.1177/1179670717749231

Vancouver

Shimada R, Tsukahara K, Takase S, Okamoto I, Sato H, Katsube Y, et al. Chemoradiotherapy With Generic Cisplatin Formulations for Head and Neck Cancers. Japanese Clinical Medicine. 2018. doi:10.1177/1179670717749231

BibTeX
@article{Shimada2018,
  author = {Shimada, Rie and Tsukahara, Kiyoaki and Takase, Soichiro and Okamoto, Isaku and Sato, Hiroki and Katsube, Yasuaki and Maruyama, Ryo and Shimizu, Akira},
  title = {Chemoradiotherapy With Generic Cisplatin Formulations for Head and Neck Cancers},
  journal = {Japanese Clinical Medicine},
  year = {2018},
  doi = {10.1177/1179670717749231}
}
Kostenlos starten →